Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127553191 | 12755319 | 1 | I | 20160822 | 20160913 | 20160916 | 20160916 | EXP | CO-ABBVIE-16P-036-1727835-00 | ABBVIE | 63.67 | YR | M | Y | 78.00000 | KG | 20160916 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127553191 | 12755319 | 1 | PS | ZEMPLAR | PARICALCITOL | 1 | Intravenous (not otherwise specified) | POST DIALYSIS | D | UNKNOWN | 20819 | 5 | UG | INJECTION | |||||
| 127553191 | 12755319 | 2 | C | CLONIDINE. | CLONIDINE | 1 | 0 | Q6H | |||||||||||
| 127553191 | 12755319 | 3 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | TABLET | QD | |||||||||
| 127553191 | 12755319 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | Q12H | |||||||||||
| 127553191 | 12755319 | 5 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 | TABLET | Q12H | |||||||||
| 127553191 | 12755319 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | Q12H | |||||||||||
| 127553191 | 12755319 | 7 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127553191 | 12755319 | 1 | Hyperparathyroidism secondary |
| 127553191 | 12755319 | 2 | Product used for unknown indication |
| 127553191 | 12755319 | 3 | Product used for unknown indication |
| 127553191 | 12755319 | 4 | Product used for unknown indication |
| 127553191 | 12755319 | 5 | Product used for unknown indication |
| 127553191 | 12755319 | 6 | Product used for unknown indication |
| 127553191 | 12755319 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127553191 | 12755319 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127553191 | 12755319 | Arteriovenous fistula | |
| 127553191 | 12755319 | General physical health deterioration | |
| 127553191 | 12755319 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127553191 | 12755319 | 1 | 20151216 | 20160824 | 0 |